There's never been a disease-modifying drug for Parkinson's disease to slow its progression. Now there may be two emerging.
—GLP-1
https://t.co/CMerh986a1 @NEJM
—anti-synuclein antibody https://t.co/3DRvOabAKv
@NatureMed
We’re thrilled to welcome Dr. David Matthews as Beacon’s newly appointed Chief Business Officer! David has a scientific background in neuro and AI, and has helped commercialize breakthrough treatments and products that improve patients' lives.
https://t.co/7C4P7J8PfL @e2pi
We are excited to announce the launch of the BrightInsight Disease Management Solution! The configurable suite of digital applications includes a Patient App, Analytics Dashboards and Healthcare Provider Interfaces. https://t.co/fDSk2Q11DS
#BrightInsight#BIO2022#BIO22
We are excited to announce our partnership with Sanofi! The partnership will bring to market a next generation digital companion application & supports Sanofi’s digital strategy to create more engaging patient experiences. Learn more about the partnership: https://t.co/xXtVlRx4yY
Congrats to @Brightinsightco for their latest announcement with #Sanofi. BrightInsight and Sanofi will bring to market a next-gen digital companion app for one of Sanofi’s most important treatments with the aim of enhancing patients’ healthcare experiences and outcomes.
Today BrightInsight announced our $101M Series C funding led by @gcvp! This funding will enable #BrightInsight to continue our hypergrowth, and to support the development and launch of game-changing #digitalhealth solutions for our customers. https://t.co/U03dfqRuW8
We are very excited to share that #BrightInsight made @LinkedIn’s 2020 Top Startups List! #LinkedInTopStartups is an annual ranking of the top emerging startups to work for globally. Learn more: https://t.co/0tbI18ekUF
Yesterday was a big day for us! We announced a Series B #funding round of $40M and wanted to share this fun video featuring our amazing team members, their families, and their dogs celebrating the #SeriesB! @insightpartners@nlvpartners@EclipseVentures https://t.co/owrZFXsKCA
BrightInsight announces global #digitalhealth partnership with @AstraZeneca: AstraZeneca selects #BrightInsight Platform to develop & host its digital health devices, apps, algorithms & Software as a Medical Device within a regulatory-compliant environment https://t.co/fmNnOODUMr
New webcast with @googlecloud is up now! #BrightInsight's Paul Schultz and @Google's @gbrail discuss API-Powered Digital Ecosystems and how to drive better patient outcomes with a medical-grade IoT platform powered by APIs: https://t.co/ek7LZdpstJ